D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 67 Citations 14,743 274 World Ranking 5279 National Ranking 122

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Enzyme
  • Cancer

Biochemistry, Tumor necrosis factor alpha, Chromogranin A, Receptor and Cancer research are his primary areas of study. His Tumor necrosis factor alpha study incorporates themes from Cytokine, Vascular permeability, NGR-hTNF, Cytotoxicity and Pharmacology. Chromogranin A is a primary field of his research addressed under Internal medicine.

His research in Receptor tackles topics such as Molecular biology which are related to areas like Cell surface receptor, Epidermal growth factor and Urokinase. His Cancer research research is multidisciplinary, relying on both Endothelial stem cell, Cytotoxic T cell, Toxicity and Pathology. The study incorporates disciplines such as Blood vessel, Chemotherapy and Neuroblastoma in addition to Pathology.

His most cited work include:

  • Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure (485 citations)
  • The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. (424 citations)
  • Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. (403 citations)

What are the main themes of his work throughout his whole career to date?

Angelo Corti mainly investigates Chromogranin A, Internal medicine, Tumor necrosis factor alpha, Cancer research and Biochemistry. The Chromogranin A study combines topics in areas such as Neuroendocrine tumors, Secretory protein, Angiogenesis and Cell biology. He works mostly in the field of Internal medicine, limiting it down to topics relating to Endocrinology and, in certain cases, Endothelial stem cell and Inflammation, as a part of the same area of interest.

His Tumor necrosis factor alpha study combines topics in areas such as Receptor, Melanoma, Cytokine and Pharmacology. His Cancer research study also includes fields such as

  • In vivo that connect with fields like Neuroblastoma and Molecular biology,
  • In vitro together with Cell culture. His work in Biochemistry covers topics such as Epitope which are related to areas like Monoclonal antibody.

He most often published in these fields:

  • Chromogranin A (26.58%)
  • Internal medicine (24.58%)
  • Tumor necrosis factor alpha (22.59%)

What were the highlights of his more recent work (between 2013-2021)?

  • Chromogranin A (26.58%)
  • Internal medicine (24.58%)
  • Cancer research (18.60%)

In recent papers he was focusing on the following fields of study:

Chromogranin A, Internal medicine, Cancer research, Angiogenesis and Endocrinology are his primary areas of study. His Chromogranin A study is associated with Pathology. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Oncology and Cardiology.

His work deals with themes such as Tumor necrosis factor alpha, Cytokine, Immunology, In vitro and Doxorubicin, which intersect with Cancer research. His study in Angiogenesis is interdisciplinary in nature, drawing from both Cancer, Pathogenesis, Pancreastatin, Pathophysiology and Cell biology. His Peptide research integrates issues from Receptor and Integrin.

Between 2013 and 2021, his most popular works were:

  • Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression (58 citations)
  • Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads. (38 citations)
  • NGR-tagged nano-gold: A new CD13-selective carrier for cytokine delivery to tumors. (35 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Enzyme
  • Cancer

His primary scientific interests are in Immunology, Internal medicine, Cancer research, Angiogenesis and Tumor necrosis factor alpha. He combines subjects such as Endocrinology and Oncology with his study of Internal medicine. His research in Endocrinology intersects with topics in Cerebrospinal fluid, Chromogranin A and Cell biology.

He has included themes like Biochemistry and Cell adhesion in his Cell biology study. He has researched Angiogenesis in several fields, including Endothelial stem cell, Monoclonal gammopathy of undetermined significance and Protein kinase B. The various areas that Angelo Corti examines in his Tumor necrosis factor alpha study include Cytokine, Tumor microenvironment, Melanoma, Cell therapy and Immunotherapy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

Roberto Ferrari;Tiziana Bachetti;Roberta Confortini;Cristina Opasich.
Circulation (1995)

733 Citations

The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.

E Appella;E A Robinson;S J Ullrich;M P Stoppelli.
Journal of Biological Chemistry (1987)

657 Citations

Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.

M P Stoppelli;A Corti;A Soffientini;G Cassani.
Proceedings of the National Academy of Sciences of the United States of America (1985)

649 Citations

Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).

Flavio Curnis;Angelina Sacchi;Laura Borgna;Fulvio Magni.
Nature Biotechnology (2000)

501 Citations

Autocrine saturation of pro-urokinase receptors on human A431 cells.

M.Patrizia Stoppelli;Carlo Tacchetti;M.Vittoria Cubellis;Angelo Corti.
Cell (1986)

443 Citations

Vascular Damage and Anti-angiogenic Effects of Tumor Vessel-Targeted Liposomal Chemotherapy

Fabio Pastorino;Chiara Brignole;Danilo Marimpietri;Michele Cilli.
Cancer Research (2003)

384 Citations

Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.

Flavio Curnis;Gianluigi Arrigoni;Angelina Sacchi;Lucia Fischetti.
Cancer Research (2002)

344 Citations

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration.

Flavio Curnis;Angelina Sacchi;Angelo Corti.
Journal of Clinical Investigation (2002)

312 Citations

Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.

Vincent J. Hearing;Lloyd W. Law;Angelo Corti;Ettore Appella.
Cancer Research (1988)

294 Citations

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.

Fabio Pastorino;Chiara Brignole;Daniela Di Paolo;Bice Nico.
Cancer Research (2006)

281 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Angelo Corti

Keld Danø

Keld Danø

Copenhagen University Hospital

Publications: 52

Horst Kessler

Horst Kessler

Technical University of Munich

Publications: 36

Mirco Ponzoni

Mirco Ponzoni

Istituto Giannina Gaslini

Publications: 36

Niels Behrendt

Niels Behrendt

University of Copenhagen

Publications: 36

Wadih Arap

Wadih Arap

University of New Mexico

Publications: 35

Francesco Blasi

Francesco Blasi

University of Milan

Publications: 34

Michael Ploug

Michael Ploug

University of Copenhagen

Publications: 32

Dario Neri

Dario Neri

ETH Zurich

Publications: 30

Renata Pasqualini

Renata Pasqualini

University of New Mexico

Publications: 30

Douglas L. Mann

Douglas L. Mann

Washington University in St. Louis

Publications: 29

Domenico Ribatti

Domenico Ribatti

University of Bari Aldo Moro

Publications: 28

Erkki Ruoslahti

Erkki Ruoslahti

Discovery Institute

Publications: 28

Dominique Aunis

Dominique Aunis

Grenoble Alpes University

Publications: 27

Daniel T. O'Connor

Daniel T. O'Connor

University of California, San Diego

Publications: 25

Manfred Schmitt

Manfred Schmitt

Technical University of Munich

Publications: 24

Andrew P. Mazar

Andrew P. Mazar

Northwestern University

Publications: 24

Trending Scientists

Fei-Yue Wang

Fei-Yue Wang

Chinese Academy of Sciences

Dietrich Stoyan

Dietrich Stoyan

TU Bergakademie Freiberg

Amay J. Bandodkar

Amay J. Bandodkar

North Carolina State University

Yuanping Yi

Yuanping Yi

Chinese Academy of Sciences

François-Xavier Coudert

François-Xavier Coudert

Chimie ParisTech

Rainer Herges

Rainer Herges

Kiel University

Thomas W. Healy

Thomas W. Healy

University of Melbourne

Dongpeng Yan

Dongpeng Yan

Beijing Normal University

Ross W. Wein

Ross W. Wein

University of Alberta

Peter Angel

Peter Angel

Karlsruhe Institute of Technology

Ken-ichi Hosoya

Ken-ichi Hosoya

University of Toyama

Bo H. Svensson

Bo H. Svensson

Linköping University

Janet E. Nichol

Janet E. Nichol

University of Sussex

Catharina A. Hartman

Catharina A. Hartman

University Medical Center Groningen

Eva Gilboa-Schechtman

Eva Gilboa-Schechtman

Bar-Ilan University

Jean Paul Sartre

Jean Paul Sartre

Université Paris Cité

Something went wrong. Please try again later.